Therapeutic drug monitoring of letermovir in allogeneic hematopoietic cell transplant recipients: where are we?

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/41790532

Catia Marzolini; Dela Wordi; Françoise Livio; Hong-Tham Nguyen; Marta Boffito; Oriol Manuel

Mar 6, 2026